
Irina Neagu
Examiner (ID: 6332, Phone: (571)270-5908 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1629 |
| Total Applications | 887 |
| Issued Applications | 384 |
| Pending Applications | 104 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9244855
[patent_doc_number] => 08609134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same'
[patent_app_type] => utility
[patent_app_number] => 12/877848
[patent_app_country] => US
[patent_app_date] => 2010-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6126
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12877848
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/877848 | Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same | Sep 7, 2010 | Issued |
Array
(
[id] => 9469041
[patent_doc_number] => 08722672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-13
[patent_title] => 'Topical pharmaceutical composition including rel-N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4′-(trifluoromethoxY)-[1,1′-biphenyl]-3-carboxamide'
[patent_app_type] => utility
[patent_app_number] => 13/386125
[patent_app_country] => US
[patent_app_date] => 2010-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6666
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386125
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/386125 | Topical pharmaceutical composition including rel-N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4′-(trifluoromethoxY)-[1,1′-biphenyl]-3-carboxamide | Jul 19, 2010 | Issued |
Array
(
[id] => 8199408
[patent_doc_number] => 20120122873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'AMINO DERIVATIVES OF DIHYDRO-1,3,5-TRIAZINE USED IN THE TREATMENT OF ISCHEMIA AND/OR REPERFUSION RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/384249
[patent_app_country] => US
[patent_app_date] => 2010-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4868
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122873.pdf
[firstpage_image] =>[orig_patent_app_number] => 13384249
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/384249 | Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases | Jul 15, 2010 | Issued |
Array
(
[id] => 8221806
[patent_doc_number] => 20120135997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/384364
[patent_app_country] => US
[patent_app_date] => 2010-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 95293
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384364
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/384364 | PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND | Jul 14, 2010 | Abandoned |
Array
(
[id] => 8186805
[patent_doc_number] => 20120115895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'TRICYCLIC INDOLE-DERIVED SPIRO DERIVATIVES AS CRTH2 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/383857
[patent_app_country] => US
[patent_app_date] => 2010-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12868
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115895.pdf
[firstpage_image] =>[orig_patent_app_number] => 13383857
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383857 | TRICYCLIC INDOLE-DERIVED SPIRO DERIVATIVES AS CRTH2 MODULATORS | Jul 13, 2010 | Abandoned |
Array
(
[id] => 8186724
[patent_doc_number] => 20120115872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'COMBINATION OF A SODIUM-PROTON EXCHANGER INHIBITOR AND OF A DIHYDRO-1,3,5-TRIAZINE AMINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/383907
[patent_app_country] => US
[patent_app_date] => 2010-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4224
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115872.pdf
[firstpage_image] =>[orig_patent_app_number] => 13383907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383907 | COMBINATION OF A SODIUM-PROTON EXCHANGER INHIBITOR AND OF A DIHYDRO-1,3,5-TRIAZINE AMINE DERIVATIVE | Jun 17, 2010 | Abandoned |
Array
(
[id] => 10876342
[patent_doc_number] => 08901128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-02
[patent_title] => 'Pharmaceutical compositions of ranolazine'
[patent_app_type] => utility
[patent_app_number] => 13/322846
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2634
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322846
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/322846 | Pharmaceutical compositions of ranolazine | May 25, 2010 | Issued |
Array
(
[id] => 10844619
[patent_doc_number] => 08871795
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Pharmaceutical oral telmisartan solution'
[patent_app_type] => utility
[patent_app_number] => 13/321216
[patent_app_country] => US
[patent_app_date] => 2010-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3059
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321216
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321216 | Pharmaceutical oral telmisartan solution | May 18, 2010 | Issued |
Array
(
[id] => 8173686
[patent_doc_number] => 20120108563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'Methods Of Treating Liposarcoma'
[patent_app_type] => utility
[patent_app_number] => 13/321036
[patent_app_country] => US
[patent_app_date] => 2010-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21728
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108563.pdf
[firstpage_image] =>[orig_patent_app_number] => 13321036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321036 | Methods Of Treating Liposarcoma | May 18, 2010 | Abandoned |
Array
(
[id] => 7818556
[patent_doc_number] => 20120065176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'TREATMENT OF MUSCLE DISEASE CHARACTERIZED BY INSULIN RESISTANCE'
[patent_app_type] => utility
[patent_app_number] => 13/320906
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23316
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065176.pdf
[firstpage_image] =>[orig_patent_app_number] => 13320906
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320906 | Treatment of muscle disease characterized by insulin resistance | May 17, 2010 | Issued |
Array
(
[id] => 8221800
[patent_doc_number] => 20120136007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING DEGENERATIVE AND ISCHEMIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/320348
[patent_app_country] => US
[patent_app_date] => 2010-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 30271
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320348
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320348 | Methods and compositions for treating degenerative and ischemic disorders | May 13, 2010 | Issued |
Array
(
[id] => 8199401
[patent_doc_number] => 20120122860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS'
[patent_app_type] => utility
[patent_app_number] => 13/318760
[patent_app_country] => US
[patent_app_date] => 2010-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101419
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122860.pdf
[firstpage_image] =>[orig_patent_app_number] => 13318760
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318760 | SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS | May 3, 2010 | Abandoned |
Array
(
[id] => 8160223
[patent_doc_number] => 20120101064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES'
[patent_app_type] => utility
[patent_app_number] => 13/266976
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76253
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101064.pdf
[firstpage_image] =>[orig_patent_app_number] => 13266976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266976 | Imidazole derivatives and their use as modulators of cyclin dependent kinases | Apr 29, 2010 | Issued |
Array
(
[id] => 7818611
[patent_doc_number] => 20120065231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'THIOPHENE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/266760
[patent_app_country] => US
[patent_app_date] => 2010-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19912
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065231.pdf
[firstpage_image] =>[orig_patent_app_number] => 13266760
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266760 | THIOPHENE DERIVATIVE | Apr 27, 2010 | Abandoned |
Array
(
[id] => 8221839
[patent_doc_number] => 20120136048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'TOPICAL, PERIOCULAR, OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/266240
[patent_app_country] => US
[patent_app_date] => 2010-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10841
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266240
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266240 | TOPICAL, PERIOCULAR, OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES | Apr 26, 2010 | Abandoned |
Array
(
[id] => 8095725
[patent_doc_number] => 20120083472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR PROMOTING THE HEALING OF WOUNDS AND CONTAINING LYSOPHOSPHATIDIC ACID AND AN ADENYLYL CYCLASE INHIBITOR AS ACTIVE INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/322874
[patent_app_country] => US
[patent_app_date] => 2010-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8574
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083472.pdf
[firstpage_image] =>[orig_patent_app_number] => 13322874
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/322874 | PHARMACEUTICAL COMPOSITION FOR PROMOTING THE HEALING OF WOUNDS AND CONTAINING LYSOPHOSPHATIDIC ACID AND AN ADENYLYL CYCLASE INHIBITOR AS ACTIVE INGREDIENTS | Apr 25, 2010 | Abandoned |
Array
(
[id] => 7778536
[patent_doc_number] => 20120040991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => '3-AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/265915
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55545
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040991.pdf
[firstpage_image] =>[orig_patent_app_number] => 13265915
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265915 | 3-AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS | Apr 22, 2010 | Abandoned |
Array
(
[id] => 8858640
[patent_doc_number] => 08461175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => '1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/265981
[patent_app_country] => US
[patent_app_date] => 2010-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27514
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265981
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265981 | 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof | Apr 21, 2010 | Issued |
Array
(
[id] => 8186795
[patent_doc_number] => 20120115891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHOD FOR THE INDUCTION OF A REWARD RESPONSE BY MODULATION OF DOPAMINERGIC SYSTEMS IN THE CENTRAL NERVOUS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 13/264586
[patent_app_country] => US
[patent_app_date] => 2010-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4565
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115891.pdf
[firstpage_image] =>[orig_patent_app_number] => 13264586
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/264586 | METHOD FOR THE INDUCTION OF A REWARD RESPONSE BY MODULATION OF DOPAMINERGIC SYSTEMS IN THE CENTRAL NERVOUS SYSTEM | Apr 15, 2010 | Abandoned |
Array
(
[id] => 8095787
[patent_doc_number] => 20120083492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'IMIDAZOPYRAZINES FOR USE AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/264544
[patent_app_country] => US
[patent_app_date] => 2010-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61356
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083492.pdf
[firstpage_image] =>[orig_patent_app_number] => 13264544
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/264544 | Imidazopyrazines for use as kinase inhibitors | Apr 15, 2010 | Issued |